Loading...
XNYS
OHI
Market cap10bUSD
May 08, Last price  
35.55USD
1D
-0.31%
1Q
-6.25%
Jan 2017
13.72%
Name

Omega Healthcare Investors Inc

Chart & Performance

D1W1MN
No data to show
P/E
25.32
P/S
9.79
EPS
1.40
Div Yield, %
5.65%
Shrs. gr., 5y
4.02%
Rev. gr., 5y
2.51%
Revenues
1.05b
+10.70%
105,812,000135,693,000159,558,000193,762,000197,438,000258,321,000292,204,000350,460,000418,714,000504,787,000743,617,000900,827,000908,385,000881,682,000928,830,000892,381,0001,062,809,000878,244,000949,740,0001,051,390,000
Net income
406m
+67.78%
36,688,00055,697,00069,374,00078,137,00082,111,00058,436,00052,606,000120,698,000172,521,000221,349,000224,524,000366,415,000100,419,000281,578,000341,123,000159,327,000416,739,000426,927,000242,180,000406,326,000
CFO
749m
+21.32%
72,957,00062,811,00084,542,00089,328,000147,223,000157,563,000169,771,000208,271,000279,949,000337,540,000463,885,000625,791,000577,912,000499,373,000553,747,000708,256,000722,136,000625,727,000617,736,000749,430,000
Dividend
Aug 05, 20240.67 USD/sh
Earnings
Jul 30, 2025

Profile

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
URL
https://www.omegahealthcare.com/
IPO date
Aug 07, 1992
Employees
52
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,051,390
10.70%
949,740
8.14%
878,244
-17.37%
Cost of revenue
102,562
188,472
84,897
Unusual Expense (Income)
NOPBT
948,828
761,268
793,347
NOPBT Margin
90.25%
80.16%
90.33%
Operating Taxes
10,858
6,255
4,561
Tax Rate
1.14%
0.82%
0.57%
NOPAT
937,970
755,013
788,786
Net income
406,326
67.78%
242,180
-43.27%
426,927
2.44%
Dividends
(685,445)
(643,867)
(632,893)
Dividend yield
6.70%
8.38%
9.27%
Proceeds from repurchase of equity
1,235,657
336,402
(134,155)
BB yield
-12.07%
-4.38%
1.96%
Debt
Debt current
426,626
19,246
Long-term debt
4,838,859
4,733,709
5,267,308
Deferred revenue
5,601,881
Other long-term liabilities
1,508
(5,642,849)
Net debt
4,231,808
4,529,116
4,810,531
Cash flow
Cash from operating activities
749,430
617,736
625,727
CAPEX
(47,221)
Cash from investing activities
(671,164)
(770)
442,853
Cash from financing activities
26,319
(473,310)
(789,447)
FCF
(749,095)
1,830,069
155,374
Balance
Cash
518,340
442,810
297,103
Long term investments
88,711
188,409
178,920
Excess cash
554,482
583,732
432,111
Stockholders' equity
244,809
(2,908,907)
(2,510,921)
Invested Capital
9,324,889
11,789,802
11,560,069
ROIC
8.88%
6.47%
6.79%
ROCE
9.91%
8.57%
8.73%
EV
Common stock shares outstanding
270,450
250,451
244,290
Price
37.85
23.45%
30.66
9.70%
27.95
-5.54%
Market cap
10,236,532
33.31%
7,678,828
12.46%
6,827,906
-5.56%
EV
14,662,506
12,395,651
11,832,350
EBITDA
1,253,476
1,080,950
1,125,754
EV/EBITDA
11.70
11.47
10.51
Interest
221,716
235,529
233,244
Interest/NOPBT
23.37%
30.94%
29.40%